Slight revisions to the outlook overshadow the good Q3 results

30/10/24 -"Wolters Kluwer released impressive 9M results, with continuous strong organic revenue growth and profitability figures. However, although the guidance was reiterated at the group level, Health ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

30/10/24

Download

You may also be interested by these reports :

21/11/25

CTS Eventim

CTS Eventim released very good Q3 figures, which notably surpassed market consensus expectations on profitability, and reiterated its guidance for ...

18/11/25

WOLTERS KLUWER

Your obvious AI quality call (II)

17/11/25

Informa

Informa unveiled an attractively refined guidance for the 2025-2028 period for its CMD, which is broadly in line with our estimates. There are no ...

14/11/25

ProSiebenSat.1 Media

MFE launched an offer in March at €5.75 per share, later increasing it to €8 (€4.45 in cash and the remainder in MFE shares). On 4 September, MFE ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue